Watch Ticker

Adaptive Biotechnologies Corporation Common Stock

Go to Adaptive Biotechnologies Corporation Common Stock Website

$10.33

0.00 (0.00%)

Live

Previous Close

$10.33

Day Range

$0 - $0

Previous Day Range

$10.02 - $10.445

Market Cap

$1.6 billion USD

Day Vol.

Previous Day Vol.

1.7 million

Currency

USD

Primary Exchange

Nasdaq

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Researchandmarkets.Com - U.S. Minimal Residual Disease Testing Market Trends Analysis Report 2025-2033 | Integration with Personalized Medicines, & Rising Incidence and Prevalence of Hematological Malignancies Fueling Growth

The U.S. minimal residual disease testing market is projected to reach $2020 million by 2033, growing at a 9.38% CAGR, driven by rising cancer rates and advancements in precision medicine technologies like NGS and flow cytometry.

Related tickers: TWST, TMO, ILMN, ADPT, NTRA.

Read Full Article

Adaptive Biotechnologies Corporation - Adaptive Biotechnologies Highlights New Data at 2025 ASCO Annual Meeting and EHA 2025 Congress Demonstrating How clonoSEQ® MRD Assessment is Optimizing Patient Care and Drug Development in Lymphoid Cancers

Adaptive Biotechnologies presented new data on the use of its clonoSEQ test for measurable residual disease (MRD) assessment in various blood cancer types at major medical conferences.

Related tickers: ADPT.

Read Full Article

Trending Tickers

Please sign in to view